Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 202
Filtrar
Más filtros

Intervalo de año de publicación
2.
Heart Surg Forum ; 24(3): E575-E577, 2021 Jun 23.
Artículo en Inglés | MEDLINE | ID: mdl-34173769

RESUMEN

Severe bronchospasm during cardiopulmonary bypass is an unusual but potentially fatal event. No literature previously has reported such an event observed during surgery for type A aortic dissection. Herein, we report on a case of severe bronchospasm following cardiopulmonary bypass, during aortic surgery for type A aortic dissection. Bronchospasm did not respond to any conventional therapy, necessitating extracorporeal membrane oxygenation. Extracorporeal membrane oxygenation thus serves as an alternative and effective therapy for refractory bronchospasm.


Asunto(s)
Aneurisma de la Aorta Torácica/cirugía , Disección Aórtica/cirugía , Espasmo Bronquial/etiología , Oxigenación por Membrana Extracorpórea/métodos , Complicaciones Intraoperatorias/etiología , Procedimientos Quirúrgicos Vasculares/efectos adversos , Disección Aórtica/diagnóstico , Aneurisma de la Aorta Torácica/diagnóstico , Espasmo Bronquial/diagnóstico , Espasmo Bronquial/terapia , Broncoscopía , Angiografía por Tomografía Computarizada , Humanos , Complicaciones Intraoperatorias/diagnóstico , Complicaciones Intraoperatorias/terapia , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad
3.
Am J Obstet Gynecol MFM ; 2(2): 100111, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32518902

RESUMEN

The worldwide incidence of coronavirus disease 2019 (COVID-19) infection is rapidly increasing, but there exists limited information on coronavirus disease 2019 in pregnancy. Here, we present our experience with 7 confirmed cases of coronavirus disease 2019 in pregnancy presenting to a single large New York City tertiary care hospital. Of the 7 patients, 5 presented with symptoms of coronavirus disease 2019, including cough, myalgias, fevers, chest pain, and headache. Of the 7 patients, 4 were admitted to the hospital, including 2 who required supportive care with intravenous hydration. Of note, the other 2 admitted patients who were asymptomatic on admission to the hospital, presenting instead for obstetrically indicated labor inductions, became symptomatic after delivery, each requiring intensive care unit admission.


Asunto(s)
COVID-19/terapia , Portador Sano , Complicaciones Infecciosas del Embarazo/terapia , Lesión Renal Aguda/etiología , Lesión Renal Aguda/fisiopatología , Adulto , Anestesia General , Antibacterianos/uso terapéutico , Antihipertensivos/uso terapéutico , Azitromicina/uso terapéutico , Espasmo Bronquial/terapia , COVID-19/complicaciones , COVID-19/diagnóstico , COVID-19/fisiopatología , Ceftriaxona/uso terapéutico , Cesárea , Diabetes Mellitus Tipo 2/complicaciones , Inhibidores Enzimáticos/uso terapéutico , Femenino , Fiebre/fisiopatología , Personal de Salud , Hospitalización , Humanos , Hidroxicloroquina/uso terapéutico , Hipertensión/complicaciones , Hipertensión/tratamiento farmacológico , Unidades de Cuidados Intensivos , Intubación Intratraqueal , Trabajo de Parto Inducido , Ciudad de Nueva York , Nicardipino/uso terapéutico , Exposición Profesional , Terapia por Inhalación de Oxígeno , Hemorragia Posparto/terapia , Embarazo , Complicaciones Cardiovasculares del Embarazo/tratamiento farmacológico , Complicaciones Infecciosas del Embarazo/diagnóstico , Complicaciones Infecciosas del Embarazo/fisiopatología , Embarazo en Diabéticas , Respiración Artificial , SARS-CoV-2 , Inercia Uterina/terapia
4.
J Natl Med Assoc ; 111(5): 490-499, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31078287

RESUMEN

BACKGROUND: Anesthesia providers in low- and middle-income countries face many challenges, including poor availability of functioning equipment designed to meet their environmental, organizational, and resource constraints. These are serious global health disparities which threaten access to care and patient safety for those who receive surgical care. In this study, we conducted a simulation-based human factors analysis of the Universal Anaesthesia Machine (UAM®), a device designed to support anesthesia providers in austere medical settings. Our team anticipated the introduction of the UAM® to the two major referral hospitals in Freetown, Sierra Leone. A prior observational study had identified these two hospitals as having environmental conditions consistent with an austere environment: an unstable electrical grid, as well as limited access to compressed oxygen, biomedical support, and consumables. Although the Baltimore simulation environment cannot reproduce all of the challenges present in a resource-constrained environment such as Sierra Leone, the major impediments to standard anesthesia machine functionality and human factors-associated use can be reproduced with the use of high-fidelity simulation. Using anesthesia care providers who have limited UAM® familiarity, this study allowed for the examination of machine-user issues in a controlled environment in preparation for further field studies concerning equipment introduction, training and device deployment in Sierra Leone. The goals of this study were: 1. to assess the usability of the UAM® (machine-user interface, simulated patient use, symbology, etc.) across different provider user groups during simulation of use in scenarios depicting routine use in healthy patients, use in clinically challenging patients and use in environmentally-challenging scenarios in a controlled setting devoid of patient risk, and 2. To gather feedback on available UAM manuals and cognitive aides and UAM usability issues in order to guide development of curricula for training providers on use of the UAM® in the intended austere clinical environments. METHODS: Residents, fellows, attending physician anesthesiologists, student nurse anesthetists, and nurse anesthetists participated in a variety of simulations involving the Universal Anaesthesia Machine® at the Johns Hopkins Medicine Simulation Center between September 2012 and July 2013. Data collected included participant demographics, performance during simulation scenarios captured with critical action checklists, workload ratings captured with the National Aeronautics and Space Administration Task Load Index (NASA TLX), and participant reactions to UAM® use captured through a post-session survey and semi-structured usability debriefing. The scenarios were: 1. normal use (machine check, induction, and maintenance of an uneventful case), 2. use in a challenging clinical condition (acute onset of bronchospasm) and 3.use in an adverse environmental event (power failure). Critical action checklists and workload ratings were analyzed by Analysis of Covariance (ANCOVA) to control for participant demographics. Usability debriefings were analyzed qualitatively. RESULTS: Thirty-five anesthesia providers participated in the study. Overall participant ratings, observations of performance in simulation scenarios, and usability debriefings indicated a high level of usability for the UAM®. Mean participant ratings were high for ease of use (5.4 ± 0.96) and clarity of instruction (6.2 ± 0.87) on a 7-point scale in which higher ratings indicate more positive perceptions. After adjusting for clinical experience, workload ratings were significantly higher in the bronchospasm scenario than in the normal/routine use (P = 0.046; 95% CI, 0.33-34.7) or power failure scenarios (P = 0.012; 95% CI, 5.24-37.9). Thirty-two specific usability issues were identified and grouped into five themes: device design and labeling, machine use during simulation scenarios, user-anticipated errors or hazards, curriculum issues, and overall impressions of the UAM®. CONCLUSIONS: The UAM® design addresses many of the key challenges facing anesthesia providers in resource-constrained settings. The simulation-based human factors evaluation described here successfully identified opportunities for continued refinement of the initial device design as well as issues to be addressed in future curricula and cognitive aides.


Asunto(s)
Anestesia General/instrumentación , Actitud del Personal de Salud , Países en Desarrollo , Carga de Trabajo , Adulto , Anestesiología/educación , Anestesiología/instrumentación , Baltimore , Espasmo Bronquial/terapia , Lista de Verificación , Simulación por Computador , Curriculum , Diseño de Equipo , Ergonomía , Humanos , Sistemas Hombre-Máquina , Persona de Mediana Edad , Simulación de Paciente , Sierra Leona
5.
J Allergy Clin Immunol Pract ; 7(7): 2194-2204.e7, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30857939

RESUMEN

BACKGROUND: Despite numerous efforts to describe the clinical manifestations and the epidemiology of perioperative hypersensitivity (POH), there remains room to increase awareness among anesthetists and immunologists/allergists. OBJECTIVE: To report the findings of a 17-year survey of suspected POH in Antwerp, Belgium. METHODS: We analyzed clinical and diagnostic data from 715 patients referred because of a suspected POH reaction, between January 1, 2001, and May 31, 2018. A total of 456 patients demonstrating a POH could be queried about subsequent anesthesia. RESULTS: A total of 608 cases formed the final dataset; 208 had a non-life-threatening reaction and 400 a life-threatening reaction. In life-threatening reactions, hypotension was predominating. In the non-life-threatening reactions, 83.9% of the patients displayed cutaneous manifestations. In life-threatening reactions, intravenous adrenaline and fluids were administered in 75.7% and 31%, respectively, and 41.3% had their intervention abandoned. Mast cell activation (MCA) was mainly, but not exclusively, observed in severe grades but did not predict the mechanistic process nor the culprit. A cause was identified in 77.8% of severe and 48.6% of milder cases. Main culprits were neuromuscular blocking agents, latex, cefazolin, and dyes. A total of 156 cases had uneventful anesthesia, except 1 patient who was inadvertently re-exposed to hidden chlorhexidine. CONCLUSIONS: This study highlights that there is room for an improved acute management and an optimized diagnostic workup that should not be restricted to patients with severe reactions and/or showing MCA.


Asunto(s)
Anafilaxia/terapia , Hipersensibilidad a las Drogas/terapia , Hipersensibilidad al Látex/terapia , Periodo Perioperatorio , Adulto , Anafilaxia/inducido químicamente , Anafilaxia/diagnóstico , Anafilaxia/fisiopatología , Angioedema/fisiopatología , Angioedema/terapia , Antibacterianos/efectos adversos , Antiinfecciosos Locales/efectos adversos , Prueba de Desgranulación de los Basófilos , Bélgica , Espasmo Bronquial/fisiopatología , Espasmo Bronquial/terapia , Reanimación Cardiopulmonar , Cefazolina/efectos adversos , Niño , Clorhexidina/efectos adversos , Colorantes/efectos adversos , Erupciones por Medicamentos/etiología , Erupciones por Medicamentos/fisiopatología , Erupciones por Medicamentos/terapia , Hipersensibilidad a las Drogas/diagnóstico , Hipersensibilidad a las Drogas/etiología , Hipersensibilidad a las Drogas/fisiopatología , Epinefrina , Fluidoterapia , Gelatina/efectos adversos , Humanos , Hipotensión/fisiopatología , Hipotensión/terapia , Inmunoglobulina E/metabolismo , Pruebas Intradérmicas , Hipersensibilidad al Látex/diagnóstico , Hipersensibilidad al Látex/etiología , Hipersensibilidad al Látex/metabolismo , Mastocitos , Azul de Metileno/efectos adversos , Bloqueantes Neuromusculares/efectos adversos , Colorantes de Rosanilina/efectos adversos , Índice de Severidad de la Enfermedad , Pruebas Cutáneas , Simpatomiméticos/uso terapéutico , Triptasas/metabolismo
8.
BMC Pediatr ; 18(1): 377, 2018 11 30.
Artículo en Inglés | MEDLINE | ID: mdl-30501615

RESUMEN

BACKGROUND: Bordetella pertussis can cause fatal illness with severe acute respiratory distress syndrome (ARDS) and pulmonary hypertension (PHT). CASE PRESENTATION: A 6-month-old non-vaccinated boy with B. pertussis infection who developed ARDS was treated by extracorporeal membrane oxygenation (ECMO). During his ECMO support stage, sudden occurred decreasing of ECMO flow implied increasing intrathoracic pressure. The airway spasm followed caused sudden drop of ventilator tidal volume as well as poor lung compliance. Prone position ventilation and bundle care were conducted as lung protection ventilator strategy. After 297-h of ECMO support, the patient was weaned off ECMO, and extubated one week later. CONCLUSIONS: In this patient with severe ARDS caused by Bordetella pertussis, ECMO was performed for cardiopulmonary support and rescued the infant with severe pertussis. During ECMO support period, prone position ventilation and care bundle nursing strategy contributed to the relief of continuous airway spasm.


Asunto(s)
Oxigenación por Membrana Extracorpórea , Paquetes de Atención al Paciente , Posición Prona , Respiración Artificial/métodos , Síndrome Respiratorio Agudo Grave/terapia , Tos Ferina/complicaciones , Tos Ferina/terapia , Espasmo Bronquial/etiología , Espasmo Bronquial/terapia , Humanos , Lactante , Masculino , Síndrome Respiratorio Agudo Grave/etiología
9.
Einstein (Sao Paulo) ; 16(4): eAO4199, 2018 Nov 08.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-30427479

RESUMEN

OBJECTIVE: To evaluate if distress respiratory decreases after using helium-oxygen mixture in pediatric patients diagnosed with bronchospasm. METHODS: This is a retrospective, non-randomized study that included patients diagnosed with bronchospasm, who received a helium-oxygen mixture at three time points (30, 60, and 120 minutes) according to the organization protocol singular, and were admitted to the intensive care unit, from January 2012 to December 2013. This protocol includes patients with bronchospasm who sustained a modified Wood score of moderate to severe, even after one hour of conventional treatment. RESULTS: Twenty children were included in the study. The mean score of severity of the disease at the initial moment was 5.6 (SD:2.0), and at moment 120 minutes, it was 3.4 (SD: 2.0). The severity score showed a significant improvement as of 30 minutes (p<0.001). CONCLUSION: The use of helium-oxygen mixture proved to be effective in diminishing the respiratory distress score for children with airway obstructions; it should be considered a supplementary therapeutic option, together with drug therapy, in specific clinical situations.


Asunto(s)
Espasmo Bronquial/terapia , Helio/administración & dosificación , Terapia por Inhalación de Oxígeno/métodos , Niño , Preescolar , Femenino , Humanos , Unidades de Cuidado Intensivo Pediátrico , Masculino , Ensayos Clínicos Controlados no Aleatorios como Asunto , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Factores de Tiempo , Resultado del Tratamiento
10.
Rev Pneumol Clin ; 74(6): 416-426, 2018 Dec.
Artículo en Francés | MEDLINE | ID: mdl-30442511

RESUMEN

INTRODUCTION: Scuba diving has long been contraindicated for asthmatics. Recommendations are evolving towards authorisation under certain conditions. Our objective was to review the literature on the risks associated with scuba diving among asthmatics and about recommendations on this subject. MATERIALS AND METHODS: We used the MEDLINE and LiSSa databases, until June 2018, in French, English or Spanish language, with the keywords "asthma AND diving" and "asthme plongée" respectively. References to the first degree were analyzed. RESULTS: We have included 65 articles. Risk of bronchospasm is well documented, particularly in cold and/or deep water, or in the event of exposure to allergens (compressor without filter). Nonasthmatic atopic divers may be at greater risk of developing bronchial hyper-reactivity. Although the theoretical risk exists, epidemiological studies do not seem to show an over-risk of barotrauma, decompression sickness or arterial gas embolism in asthmatics. French, British, American, Spanish and Australian societies agreed on the exclusion of patients with moderate to severe persistent asthma, FEV1<80%, active asthma in the last 48hours, exercise/cold asthma and poor physical fitness. CONCLUSION: A diver's examination should include a triple assessment: asthma control, number of exacerbations and treatment compliance. Homogenizing the recommendations would improve the framework for the practice of diving among asthmatics and allow larger studies in this population. Communicating the current recommendations remains important to divers, dive instructors and doctors in the context of the development of scuba diving.


Asunto(s)
Asma/terapia , Buceo/fisiología , Asma/epidemiología , Asma/etiología , Barotrauma/epidemiología , Barotrauma/etiología , Barotrauma/terapia , Espasmo Bronquial/epidemiología , Espasmo Bronquial/etiología , Espasmo Bronquial/terapia , Enfermedad de Descompresión/epidemiología , Enfermedad de Descompresión/etiología , Enfermedad de Descompresión/terapia , Buceo/efectos adversos , Buceo/estadística & datos numéricos , Humanos , Factores de Riesgo
11.
Ther Adv Respir Dis ; 12: 1753466618777723, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29865929

RESUMEN

BACKGROUND: Asthma is characterized by hyperresponsiveness of the airways, and exercise-induced bronchospasm (EIB) is a symptom that limits a large proportion of asthmatic patients, especially children. Continuous positive airway pressure (CPAP) leads to a reduction in the reactivity of the airways. The aim of this study was to evaluate the effect of outpatient treatment with CPAP and bilevel pressure combined with respiratory physical therapy for children and adolescents with asthma following bronchial hyperresponsiveness caused by an exercise bronchoprovocation test. METHODS: A randomized, controlled, blind, clinical trial was conducted involving 68 asthmatic children and adolescents aged 4 to 16 years divided into three groups: G1, treated with bilevel pressure (inspiratory positive airway pressure: 12 cm H2O; expiratory positive airway pressure: 8 cm H2O), G2, treated with CPAP (8 cm H2O) and G3, treated with respiratory muscle training (RMT), considered as the control group. All groups were treated at an outpatient clinic and submitted to 10 1-hour sessions, each of which also included respiratory exercises. Evaluations were performed before and after treatment and involved spirometry, an exercise bronchoprovocation test, respiratory pressures, fraction of nitric oxide (FeNO), the Asthma Control Questionnaire (ACQ6) and anthropometric variables. This study received approval from the local ethics committee (certificate number: 1487225/2016) and is registered with ClinicalTrials [ ClinicalTrials.gov identifier: NCT02939625]. RESULTS: A total of 64 patients concluded the protocol; the mean age of the patients was 10 years. All were in the ideal weight range and had adequate height ( z score: -2 to +2). The three groups demonstrated improved asthma control after the treatments, going from partial to complete control. A significant increase in maximal inspiratory pressure occurred in the three groups, with the greatest increase in the RMT group. A reduction in FeNO in the order of 17.4 parts per billion (effect size: 2.43) and a reduction in bronchial responsiveness on the exercise bronchoprovocation test occurred in the bilevel group. An improvement in FeNO on the order of 15.7 parts per billion (effect size: 2.46) and a reduction in bronchial responsiveness occurred in the CPAP group. No changes in lung function or responsiveness occurred in the RMT group. CONCLUSION: Positive pressure and respiratory exercises were effective in reducing pulmonary inflammation, exercise-innduced bronchoespasm (EIB), and increased the clinical control of asthma, as well as RMT, which also resulted in improved clinical control.


Asunto(s)
Asma Inducida por Ejercicio/terapia , Ejercicios Respiratorios , Espasmo Bronquial/terapia , Broncoconstricción , Presión de las Vías Aéreas Positiva Contínua , Pulmón/fisiopatología , Ventilación no Invasiva , Neumonía/terapia , Terapia Respiratoria/métodos , Adolescente , Factores de Edad , Asma Inducida por Ejercicio/diagnóstico , Asma Inducida por Ejercicio/fisiopatología , Brasil , Ejercicios Respiratorios/efectos adversos , Espasmo Bronquial/diagnóstico , Espasmo Bronquial/fisiopatología , Niño , Preescolar , Terapia Combinada , Presión de las Vías Aéreas Positiva Contínua/efectos adversos , Femenino , Humanos , Masculino , Ventilación no Invasiva/efectos adversos , Neumonía/diagnóstico , Neumonía/fisiopatología , Terapia Respiratoria/efectos adversos , Factores de Tiempo , Resultado del Tratamiento
13.
Anaesth Crit Care Pain Med ; 37(2): 161-166, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28882740

RESUMEN

BACKGROUND: Sleep deprivation has been associated with an increased incidence of medical errors and can jeopardise patients' safety during medical crisis management. The aim of the study was to assess the effect of sleep deprivation on the management of simulated anaesthesia crisis by residents in anaesthesiology. METHODS: A randomised, comparative, monocentric crossover study involving 48 residents in anaesthesia was performed on a high fidelity patient simulator. Each resident was evaluated in a sleep-deprived state (deprived group, after a night shift duty) and control state (control group, after a night of sleep). Performance was assessed through points obtained during crisis scenario 1 (oesophageal intubation followed by anaphylactic shock) and scenario 2 (anaesthesia-related bronchospasm followed by ventricular tachycardia). Sleep periods were recorded by actigraphy. Two independent observers assessed the performances. The primary endpoint of the study was the score obtained for each scenario. RESULTS: Resident's crisis management performance is associated with sleep deprivation (scenario 1: control=39 [33-42] points vs. deprived=26 [19-40] points, P=0.02; scenario 2: control=21 [17-24] vs. deprived=14 [12-19], P=0.01). The main errors observed were: error in drug administration and dose, delay in identification of hypotension, and missing communication with the surgical team about situation. CONCLUSIONS: The present study showed that sleep deprivation is associated with impairment of performance to manage crisis situations by residents in anaesthesia.


Asunto(s)
Anestesiólogos , Anestesiología/educación , Internado y Residencia , Privación de Sueño/psicología , Trastornos del Sueño del Ritmo Circadiano/psicología , Adulto , Anafilaxia/terapia , Anestesia/efectos adversos , Espasmo Bronquial/terapia , Competencia Clínica , Estudios Cruzados , Servicios Médicos de Urgencia , Femenino , Humanos , Hipotensión/diagnóstico , Intubación Intratraqueal , Masculino , Errores Médicos , Simulación de Paciente
14.
Clin Toxicol (Phila) ; 56(2): 126-131, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28748745

RESUMEN

BACKGROUND: Insect consumption is a common practice in the Asian culture and all over the world. We are reporting an outbreak investigation of histamine poisoning from ingestion of fried insects. METHODS: On 24 July 2014, a group of students at a seminar presented to Angthong Provincial Hospital, Thailand, with pruritic rash after ingesting snacks consisting of fried insects from a vendor. We initiated an outbreak investigation with retrospective cohort design and collected samples of remaining foods for analyses. Attack rates, relative risks and their confidence intervals (CI) were calculated. RESULTS: Out of 227 students, 28 developed illnesses that were consistent with our case definition which included, flushing, pruritus, urticarial rashes, headache, nausea, vomiting, diarrhea, dyspnea and bronchospasm. Two children were hospitalized for progressive bronchospasm overnight without serious complications. The types of food ingested included a lunch that was provided at the seminar for all students and snacks that 41 students bought from the only vendor in the vicinity. The snacks included fried grasshoppers, silkworm pupae, common green frogs, bamboo borers, crickets and meat balls. The attack rates were highest (82.6 and 85.0%) among students who ingested fried grasshoppers and silkworm pupae and lowest (4.4 and 5.3%) among those who did not ingest them, with relative risk of 18.7 (95% CI 9.6-36.4) for grasshoppers and 16.0 (95% CI 8.8-29.3) for silkworm pupae. Histamine concentrations in the fried grasshoppers and silkworm pupae were 9.73 and 7.66 mg/100g, respectively. DISCUSSION AND CONCLUSION: Through epidemiological analysis and laboratory confirmation, we have illustrated that histamine poisoning can occur from ingestion of fried insects. We postulate that histidine, which is present in high concentration in grasshoppers and silkworm pupae, is decarboxylated by bacteria to histamine, a heat stable toxin. The ingestion of histamine is responsible for the clinical pictures being reported.


Asunto(s)
Brotes de Enfermedades , Enfermedades Transmitidas por los Alimentos/epidemiología , Histamina/envenenamiento , Insectos , Adolescente , Animales , Bombyx/química , Espasmo Bronquial/inducido químicamente , Espasmo Bronquial/terapia , Estudios de Cohortes , Exantema/inducido químicamente , Femenino , Saltamontes/química , Histidina/metabolismo , Histidina/envenenamiento , Hospitalización , Humanos , Insectos/química , Masculino , Prurito/inducido químicamente , Estudios Retrospectivos , Tailandia/epidemiología , Adulto Joven
15.
Einstein (Säo Paulo) ; 16(4): eAO4199, 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-975102

RESUMEN

ABSTRACT Objective To evaluate if distress respiratory decreases after using helium-oxygen mixture in pediatric patients diagnosed with bronchospasm. Methods This is a retrospective, non-randomized study that included patients diagnosed with bronchospasm, who received a helium-oxygen mixture at three time points (30, 60, and 120 minutes) according to the organization protocol singular, and were admitted to the intensive care unit, from January 2012 to December 2013. This protocol includes patients with bronchospasm who sustained a modified Wood score of moderate to severe, even after one hour of conventional treatment. Results Twenty children were included in the study. The mean score of severity of the disease at the initial moment was 5.6 (SD:2.0), and at moment 120 minutes, it was 3.4 (SD: 2.0). The severity score showed a significant improvement as of 30 minutes (p<0.001). Conclusion The use of helium-oxygen mixture proved to be effective in diminishing the respiratory distress score for children with airway obstructions; it should be considered a supplementary therapeutic option, together with drug therapy, in specific clinical situations.


RESUMO Objetivo Avaliar se o desconforto diminui após o uso da mistura hélio-oxigênio em pacientes pediátricos com diagnóstico de broncoespasmo. Métodos Estudo retrospectivo, não randomizado, no qual foram incluídos pacientes com diagnóstico de broncoespasmo que utilizaram a mistura hélio-oxigênio em três momentos (30, 60 e 120 minutos), seguindo o protocolo institucional, internados em unidade de terapia intensiva pediátrica de janeiro de 2012 a dezembro 2013. Este protocolo incluía pacientes com diagnóstico de broncoespasmo que mantivessem escore de Wood modificado de moderado a grave, mesmo após 1 hora de tratamento convencional. Resultados Foram incluídas 20 crianças neste estudo. A média do escore de gravidade da doença no momento zero foi de 5,6 (DP:2,0) e, no momento 120 minutos, 3,4 (DP: 2,0). O escore de gravidade apresentou melhora significante a partir dos 30 minutos (p<0,001). Conclusão A utilização da mistura hélio-oxigênio mostrou-se eficaz na redução do escore de desconforto respiratório de crianças com doenças obstrutivas e deve ser considerada recurso terapêutico complementar à terapia medicamentosa em situações clínicas específicas.


Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Niño , Terapia por Inhalación de Oxígeno/métodos , Espasmo Bronquial/terapia , Helio/administración & dosificación , Factores de Tiempo , Índice de Severidad de la Enfermedad , Unidades de Cuidado Intensivo Pediátrico , Estudios Retrospectivos , Resultado del Tratamiento , Ensayos Clínicos Controlados no Aleatorios como Asunto
16.
A A Case Rep ; 8(12): 316-319, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28328587

RESUMEN

Bronchospasm appears in up to 4% of patients with obstructive lung disease or respiratory infection undergoing general anesthesia. Clinical examination alone may miss bronchospasm. As a consequence, subsequent (mis)treatment and ventilator settings could lead to pulmonary hyperinflation, hypoxia, hypercapnia, hypotension, patient-ventilator asynchrony, volutrauma, or barotrauma. Electrical impedance tomography (EIT), a new noninvasive technique, can potentially identify bronchospasms by determining regional expiratory time constants (τ) for each one of the pixels of a functional EIT image. We present the first clinical case that highlights the potential of breath-wise EIT-based τ images of the lung to quickly identify bronchospasm at the bedside, which could improve perioperative patient management and safety.


Asunto(s)
Espasmo Bronquial/diagnóstico por imagen , Broncoconstricción , Espiración , Pulmón/diagnóstico por imagen , Monitoreo Fisiológico/métodos , Pruebas en el Punto de Atención , Tomografía Computarizada por Rayos X/métodos , Adolescente , Espasmo Bronquial/fisiopatología , Espasmo Bronquial/terapia , Impedancia Eléctrica , Humanos , Pulmón/fisiopatología , Masculino , Valor Predictivo de las Pruebas , Interpretación de Imagen Radiográfica Asistida por Computador , Respiración Artificial , Factores de Tiempo
18.
Paediatr Respir Rev ; 17: 63-70, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26531217

RESUMEN

Pulmonary complications of childhood cancer treatment are frequently seen. These can lead to adverse sequelae many years after treatment, with important impact on morbidity, quality of life and mortality in childhood cancer survivors. This review addresses the effects of chemotherapy, radiotherapy, surgery and alloimmunity (in haematopoietic cell transplantation) on the lung in children. It highlights the complexity of lung damage and lung disease in relation to growth and development, infections and other external factors. Screening high risk childhood cancer survivors for treatment related late effects, with therapy based screening protocols, using full medical assessment and pulmonary function tests is important. This will lead to recognition of pulmonary sequelae of cancer treatment, early detection of lung damage in survivors and better treatment and prevention.


Asunto(s)
Antineoplásicos/efectos adversos , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Enfermedades Pulmonares/etiología , Neoplasias/terapia , Radioterapia/efectos adversos , Sobrevivientes , Obstrucción de las Vías Aéreas/etiología , Obstrucción de las Vías Aéreas/terapia , Enfermedades Bronquiales/etiología , Enfermedades Bronquiales/terapia , Espasmo Bronquial/etiología , Espasmo Bronquial/terapia , Niño , Tos/etiología , Tos/terapia , Disnea/etiología , Disnea/terapia , Humanos , Hipertensión Pulmonar/etiología , Hipertensión Pulmonar/terapia , Hipoxia/etiología , Hipoxia/terapia , Enfermedades Pulmonares/terapia , Fibrosis Pulmonar/etiología , Fibrosis Pulmonar/terapia , Neumonitis por Radiación/etiología , Neumonitis por Radiación/terapia
19.
Am J Emerg Med ; 33(6): 857.e3-5, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25572642

RESUMEN

A male patient presented with bronchospasm and acute respiratory distress. The patient had presented 2 previous episodes of severe bronchospasm following abdominal surgery, leading twice to intubation, mechanical ventilation, and conventional sedation. As the patient positively rejected a third episode of intubation + mechanical ventilation, noninvasive ventilation (pressure support = 8 cm H2O, positive end-expiratory pressure = 10 cm H2O), inhaled therapy, and clonidine orally (≈ 4 µg/kg) were combined. Over 1 to 2 hours, the acute respiratory distress disappeared. Noninvasive ventilation was discontinued on the next morning (day 2). The patient was discharged from the critical care unit on day 3 on good condition but died at a later interval from iterative bronchospasm. Evidence-based documentation of the effects of alpha-2 agonists in the setting of acute bronchospasm in the emergency department or status asthmaticus in the critical care unit is awaited.


Asunto(s)
Agonistas de Receptores Adrenérgicos alfa 2/uso terapéutico , Espasmo Bronquial/terapia , Clonidina/uso terapéutico , Ventilación no Invasiva , Enfermedad Aguda , Agonistas de Receptores Adrenérgicos alfa 2/administración & dosificación , Clonidina/administración & dosificación , Resultado Fatal , Humanos , Masculino , Recurrencia , Retratamiento
20.
J Anesth ; 29(1): 152-5, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24993492

RESUMEN

There is no strong evidence to support ventilatory management for critical limitation of expiratory flow, such as bronchospasm during anesthesia or an acute exacerbation of severe asthma and chronic obstructive pulmonary disease (COPD). Animal models cannot be used to develop reproducible experimental models for conducting mechanical ventilation strategy research relating to these etiologies due to the resulting respiratory and hemodynamic instabilities. Therefore, we developed a device model by modifying a positive end-expiratory pressure (PEEP) valve that can simulate the characteristics of airway bronchoconstriction (i.e., limited peak expiratory flow and a prolonged expiratory phase). These characteristics were found to improve upon narrowing the expiratory port. We believe that this device model will facilitate future mechanical ventilation experiments.


Asunto(s)
Espasmo Bronquial/terapia , Modelos Anatómicos , Asma/fisiopatología , Espasmo Bronquial/fisiopatología , Broncoconstricción , Simulación por Computador , Diseño de Equipo , Humanos , Respiración con Presión Positiva , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Respiración Artificial
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA